100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
NURS 6630 – Psychopharmacologic Approaches to Treatment of Psychopathology Discussions and Assignments Case Study: An Elderly Iranian Man with Alzheimer’s Disease$14.99
Add to cart
NURS 6630 – Psychopharmacologic Approaches to Treatment of Psychopathology Discussions and Assignments Case Study: An Elderly Iranian Man with Alzheimer’s Disease
NURS 6630 – Psychopharmacologic
Approaches to Treatment of
Psychopathology Discussions and
Assignments
David Mungai
[COMPANY NAME] [Company address]
, NURS 6630 – Psychopharmacologic Approaches to
Treatment of Psychopathology Discussions and
Assignments
Case Study: An Elderly Iranian Man with Alzheimer’s
Disease
Introduction
The client, Mr. Akkad is a 76 year old Iranian. Mr. Akkad’s diagnosis is
major neurocognitive disorder due to Alzheimer’s disease
(presumptive). For the MMSE, the client scores 18 out of 30 which
indicate moderate dementia. The purpose of this paper is to present
three decisions regarding the client’s medications. The paper will also
discuss factors that might impact the client’s pharmacokinetic and
pharmacodynamic processes. Finally, ethical considerations might
impact treatment plan and communication with clients will be taken
into account. NURS 6630 – Psychopharmacologic Approaches to
Treatment of Psychopathology Discussions and Assignments.
Decision Point 1
The first decision is that the client start taking Exelon (rivastigmine) 1.5
mg orally BID with an increase to 3 mg orally BID in 2 weeks.
Rationale of selecting the Decision
This decision was selected because evidence supports effectiveness of
Exelon (rivastigmine) for treatment of Alzheimer’s disease and
dementia as well (Su et al, 2015). Pathological changes present in
Dementia of the Alzheimer type involve cholinergic neuronal pathways.
Therefore, exelon (rivastigmine) exercises its therapeutic effect by
improving cholinergic function (Kandiah et al, 2017). The medication
stops breakdown of acetylcholine and hence improves synaptic
transmissions in the brain, which are related to memory and other
cognitive functions. The client has Alzheimer’s and hence has low levels
of the acetylcholine chemical within the brain. In addition, the client
has moderate dementia. FDA guidelines and evidence recommend first
dosage to be 1.5 mg BID and if the patient tolerates the dose after
treatment of at least 2 weeks, it is appropriate to increase the dosage to
3 mg BID (Birks et al, 2015).
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller StarScoreGrades. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.99. You're not tied to anything after your purchase.
